Boosting Number Of Medical Residents In U.S.Â Could Negatively Impact Developing Nations In a New York Times opinion piece that focuses on health reform in the U.S., Shannon Brownlee, a senior research fellow at the New America Foundation and David Goodman, a professor at the Dartmouth Institute for Health Policy and…
Access to Health Services
Lancet Infectious Diseases Piece Highlights Positive Results Of PEPFAR In Mozambique In a Lancet Infectious Diseases Reflection and Reaction piece, a group of “PEPFAR-implementing partners” in Mozambique counter a previous piece published in the journal that says there is “abuse” of PEPFAR money in the country. The authors contend that…
MSF Report Names Malnutrition, Inadequate Funds For HIV/AIDS, Neglected Diseases Among Top Humanitarian Crises Of 2009
Inadequate international funding for HIV/AIDS and neglected diseases as well as global malnutrition were among the top 10 humanitarian crises outlined in an annual report issued Monday by Medecins Sans Frontieres, the Associated Press reports (Astor, 12/21).
The Scientist Examines How Nonprofit, For-Profit Pharma Groups Are Working Together To Make Drugs More Affordable For Developing Countries
“With philanthropists funneling billions of dollars into biomedical research and traditional drug discovery efforts producing fewer and fewer therapies, the line between for-profit and nonprofit life science companies is beginning to blur as both sides of the divide look for new options,” The Scientist magazine writes in an article that examines the rise in collaborations between nonprofit pharmaceutical companies and for-profit groups. “More and more for-profit enterprises are experimenting with nonprofit models, while nonprofit organizations look to incorporate for-profit business practices to stay afloat.”
“[A] recent study by the World Health Organization and the International Labor Organization identified 72 different ‘social pension’ plans around the world dedicated to the elderly, the ill, or the down and out,” Newsweek writes in an article exploring the growth in welfare programs around the world. “Most countries on the [WHO/ILO] list are developing nations once considered too destitute to help their poor and that, until recently, had little or no welfare coverage at all. … While fighting inequality and helping the neediest has long been on the docket of Third World leaders, most previous attempts have been sabotaged by inefficiency, corruption, and stagnant or dysfunctional economies,” the magazine writes. “Now roaring economies in Asia, Latin America, and even Africa, coupled with better-functioning governments and sound fiscal stewardship, have stretched the policy horizons for many nations that once lived from one crisis to the next,” according to Newsweek.
Also In Global Health News: Vaccination Hampered In Cote d’Ivoire; TB And Lung Cancer; HIV Testing, Counseling In Zambia; Reducing Child, Maternal Mortality In Ghana; Male Circumcision Campaign In Kenya
Political Unrest Hampering Cote d’Ivoire’s Yellow Fever Vaccine Campaign “Unrest following Cote d’Ivoire’s presidential election is blocking a nationwide vaccination drive against yellow fever, a fatal mosquito-borne disease that is affecting people throughout the country,” IRIN reports. The immunization campaignÂ â€“ part of a global effort by WHO and UNICEF â€“…
India’s patent office “has rejected American drug maker Abbott Laboratories’ patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented,” Economic Times reports (1/4). The drug under consideration was Abbott’s “Kaletra, which combines two antivirals, [lopinavir/ritonavir and] is one of the preferred second-line treatments to fight drug-resistant HIV, according to the World Health Organization, which recommends governments include it on their list of essential medicines,” Bloomberg/Businessweek writes (Narayan, 1/4).
Lancet World Report Examines Health Risks Associated With Inaccurate TB Tests, WHO’s Upcoming Recommendations
With “scores of commercial serology tests for tuberculosis … being sold in high-burden countries,” the “WHO is due to release a negative policy recommendation â€“ the first of its kind for the organisation” â€“ after several reviews have “indicated poor performance of these tests,” Lancet World Report writes in a piece that documents the health risks associated with a growing number of inaccurate TB tests. However, “[m]anufacturers continue to claim that their tests are effective and fill a diagnostic niche, especially in sputum smear-negative patient groups,” the journal notes.
“Among HIV-negative sexual partners, male circumcision helps prevent the transmission of human papillomavirus [HPV] from men to women,” according to a study published online Thursday in the Lancet, HealthDay News/Bloomberg Businessweek reports. “However, circumcision offers only partial protection and partners must still practice safe sex, the researchers pointed out,” according to the news service (1/6).
Also In Global Health News: Sec. Clinton In Yemen; China’s Ability To Track Outbreaks; Global Health Interests Among Medical Residents; Children Of Sex Workers
During Surprise Stop In Yemen, Sec. Clinton To Highlight U.S. Commitment To Country’s Development U.S. Secretary of State Hillary Rodham Clinton arrived in Yemen Tuesday “on a diplomatically sensitive mission to broaden America’s relationship with this impoverished Arab country, a haven for Al Qaeda that has nurtured several recent terror…